Explorer les evidences

The percentage of men with sickle cell disease who had erectile dysfunction was more than twofold higher than that of men without sickle cell disease who had erectile dysfunction.

Nigeriadrépanocytosepublié 2020Blood advancesPubMeddocument de 5 observations

6,5 %The prevalence of cholelithiasis was 6.5% in younger children with sickle cell disease.

Nigeriacholelithiasis · drépanocytosepublié 2022Annals of African medicinePubMeddocument de 6 observations

1,21 %The estimated average birth prevalence of HbSS in Nigeria was 1.21%.

Nigeriadrépanocytosepublié 2021The Lancet. Haematologyeurope_pmcdocument de 6 observations

50 %In the phase 2 portion of the RISE UP trial, the haemoglobin response rate (≥1.0 g/dL increase from baseline in average haemoglobin concentration from week 10 through week 12) was 50% in the mitapivat 100 mg group.

Nigeriadrépanocytosepublié 2025The Lancet. Haematologyeurope_pmcdocument de 9 observations

58,3 %Sixty participants with SCA had 58.3% females and a mean age of 24.77 ± 7.39 years.

Nigeriadrépanocytoseobservé 2020-12-02 to 2021-03-31publié 2022The Pan African medical journalPubMeddocument de 4 observations

442 patientsSouth registered 442 patients with sickle cell disease, representing 5.7% of the total enrolled in Nigeria.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 8 observations

92 %The acceptance of newborn screening for sickle cell disease was high, at 718 (92%) among the 780 mothers.

Nigeriadrépanocytosepublié 2023West African journal of medicinePubMeddocument de 5 observations

43 patients43 of the males had priapism.

Nigeriadrépanocytosepublié 2021Hematology (Amsterdam, Netherlands)PubMeddocument de 16 observations

116 patientsHydroxyurea was administered to 116 patients aged 1.2–17 years at a mean dose of 18.5 ± 4.3 mg/kg/day over 33 months.

Nigeriadrépanocytosepublié 2021Pediatric blood & cancereurope_pmcdocument de 10 observations

2 deathsA total of 2 deaths occurred in the low-dose hydroxyurea group.

Nigeriadrépanocytosepublié 2023BloodPubMeddocument de 8 observations

1,4 %Among 17 newborns with sickle cell disease (HbSS and HbSC) identified in The Gambia, 6 (1.4%) were from the Mandinka ethnic group.

Nigeriadrépanocytosepublié 2024Hemoglobineurope_pmcdocument de 10 observations

1 %Among 490 analysed alleles from 245 homozygous sickle cell disease patients in Nigeria, five (1.0%) had the Bantu/Central African Republic haplotype.

Nigeriadrépanocytosepublié 2021The Journal of international medical researchPubMeddocument de 5 observations

22,4 %Pack cell volume (PCV) in steady state subjects was 22.4 ± 2.7.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

1 %The public health department had the least proportion of sickle cell disease cases at 1%.

Nigeriadrépanocytoseobservé 2013 to 2014publié 2022The Pan African medical journalPubMeddocument de 9 observations

47,2 %The prevalence of albuminuria was 47.2% among patients with sickle cell disease in Ahmadu Bello University Teaching Hospital, Zaria.

NigeriadrépanocytosePubMeddocument de 7 observations

XO level was significantly higher in the HbS group than in the control group.

Nigeriadrépanocytosepublié 2025Sultan Qaboos University medical journalPubMeddocument de 5 observations

40 patientsForty of the 85 SCA patients had urine specific gravity below 1.010.

Nigeriadrépanocytosepublié 2023Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 12 observations

Weight and body mass index (BMI) were significantly lower in children with sickle cell anaemia compared to controls (p = 0.010 and p = 0.029 respectively).

Nigeriadrépanocytosepublié 2024West African journal of medicinePubMeddocument de 9 observations

71 %Among 172 children with sickle cell disease, 71% (122/172) were on regular blood transfusion.

Nigeriadrépanocytosepublié 2022British journal of haematologyPubMeddocument de 7 observations

4,8 %Among 3622 enrolled sickle cell disease patients in Nigeria, 4.8% had experienced priapism.

Nigeriadrépanocytose · priapismpublié 2020Blood cells, molecules & diseaseseurope_pmcdocument de 16 observations

23,5 %The spleen was visualised in 23.5% of patients aged 15 years and older with sickle cell disease.

Nigeriadrépanocytosepublié 2023Tropical medicine & international health : TM & IHPubMeddocument de 6 observations

3,8 %The population prevalence of sickle cell disease (SCD) in the study was 3.8%.

Nigeriadrépanocytosepublié 2025West African journal of medicinePubMeddocument de 8 observations

67,1 %Two-thirds of the study participants (67.1%) indicated that they would prioritise sickle cell screening in their relationships.

Nigeriadrépanocytosepublié 2022Hematology (Amsterdam, Netherlands)PubMeddocument de 6 observations

5 x10⁹/LAbsolute lymphocyte count in crisis state subjects was 5.0 ± 1.3.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

8,8 yearsThe mean age of the cases was 8.8 years with a standard deviation of 3.2 years.

Nigeriadrépanocytosepublié 2023Ghana medical journalPubMeddocument de 7 observations